Skip to main content

Table 1 Baseline characteristics of 85 enrolled patients on whom clinical information was available

From: Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study

Variable Valuea (N = 85)
Age in years, mean ± standard deviation 66.9 ± 15.9
Male gender 33 (38.8)
Comorbid conditions
 Malignancy 41 (48.2)
 Diabetes mellitus 28 (32.9)
 Corticosteroid/Immunosuppressive therapy 22 (25.9)
 Renal insufficiency 11 (12.9)
 Chronic pulmonary disease 8 (9.4)
Exposure to healthcare/invasive devices within 30 days of current infection
 Hospital stay
  0–2 days 50 (58.8)
  3–5 days 12 (14.1)
  > 6 days 23 (27.1)
 Urinary catheter
  0–2 days 69 (81.2)
  3–5 days 7 (8.2)
  > 6 days 9 (10.6)
 Surgical procedure 18 (21.2)
Recent antibiotic use
 Within 24 h prior to enrollment 15 (17.6)
 For >48 h within 30 days prior to enrollment 32 (37.6)
Place of acquisition of infection
 Community-acquired 37 (43.5)
 Healthcare-associated 29 (34.2)
 Hospital-acquired 19 (22.3)
Site of infection
 Urinary tract 74 (87.1)
 Skin and soft tissue 6 (7.1)
 Bloodstream 4 (4.7)
 Respiratory tract 1 (1.2)
  1. aNumbers represent n (%) unless otherwise indicated